Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

NCT06679270 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Partial Lipodystrophy

Interventions

DRUG: Metreleptin

Sponsor

Amryt Pharma